Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of Chimerix's Dordaviprone?
Dordaviprone is a small molecule commercialized by Chimerix, with a leading Phase III program in Pediatric Diffuse Intrinsic Pontine Glioma....
Data Insights
Risk adjusted net present value: What is the current valuation of Chimerix's Dordaviprone?
Dordaviprone is a small molecule commercialized by Chimerix, with a leading Phase III program in Glioma. According to Globaldata, it...